2013
DOI: 10.1253/circj.cj-13-1110
|View full text |Cite
|
Sign up to set email alerts
|

Necessity of Face-to-Face Encounters With Recipients of Cardiovascular Implantable Electronic Devices With Remote Monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…Remote Monitoring After ASO of follow-up visits and hospital admissions and thus costsaving in the long term in this high-risk patient group. 21 A recent randomized trial of long-term RM showed that RM is as safe as standard follow-up in adult pacemaker patients with structurally normal hearts as well as those with structural heart disease. 22 It enables the early detection of adverse events such as arrhythmias and lead-related complications compared with conventional monitoring and allows early optimization of medical therapy in patients with ICD, CRT and pacemakers.…”
Section: Detection and Reaction Timesmentioning
confidence: 99%
“…Remote Monitoring After ASO of follow-up visits and hospital admissions and thus costsaving in the long term in this high-risk patient group. 21 A recent randomized trial of long-term RM showed that RM is as safe as standard follow-up in adult pacemaker patients with structurally normal hearts as well as those with structural heart disease. 22 It enables the early detection of adverse events such as arrhythmias and lead-related complications compared with conventional monitoring and allows early optimization of medical therapy in patients with ICD, CRT and pacemakers.…”
Section: Detection and Reaction Timesmentioning
confidence: 99%
“…As demonstrated by the Japanese HOME‐ICD study [18], it is also inevitable that false‐negative events sometimes occur. Nevertheless, according to the results of the previous studies, the interval between face‐to‐face visits for ICD/CRT‐D patients can likely be increased from 3–4 months to 6–12 months in Japan, which will undoubtedly reduce the burden on patients and medical professionals [19]. However, as shown by the REFORM trial [15], stretching the interval to 12 months may increase the number of patients who are lost to follow‐up.…”
Section: Acceptance and Safetymentioning
confidence: 99%